Amphastar stock target cut by Jefferies, maintains Buy rating
Jefferies has adjusted its price target for Amphastar Pharmaceuticals (NASDAQ: NASDAQ:), a company specializing in...
Jefferies has adjusted its price target for Amphastar Pharmaceuticals (NASDAQ: NASDAQ:), a company specializing in...
By Maytaal Angel JERUSALEM (Reuters) – Israeli Prime Minister Benjamin Netanyahu traded barbs with his...
BMO Capital Markets has maintained its Market Perform rating on Boise Cascade Company (NYSE: NYSE:)...
Revance Therapeutics (NASDAQ: NASDAQ:) saw a shift in stock rating as William Blair moved the...
Granite Point Mortgage Trust Inc . (NYSE:) stock has reached a 52-week low, dipping to...
In a year marked by significant volatility, Mesa Royalty Trust (MTR) stock has recorded a...
EDEN PRAIRIE, Minn., Aug. 12, 2024 (GLOBE NEWSWIRE) — NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)...
(Reuters) -A U.S. court has ordered bankrupt cryptocurrency exchange FTX to pay $12.7 billion in...
Westrock Coffee Company (NASDAQ: WEST), in their second quarter 2024 earnings call, has reported a...